Malignant tumor
Conditions
Interventions
68Ga-CAIX imaging group:Injection of 68Ga-CAIX molecular probe
Sponsors
The First Affiliated Hospital of Guilin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >=18, male or female; 2. The research participants possess behavioral capacity, understand and have voluntarily signed the informed consent form; 3. Patients initially diagnosed with non-hematological solid tumors or those who have previously been diagnosed with and treated for non-hematological solid tumors.
Exclusion criteria
Exclusion criteria: 1. Patients in critical condition requiring emergency treatment; 2. Individuals with drug and/or alcohol abuse, or those with allergic constitution; 3. Women in the preparation period for pregnancy, during pregnancy, and during lactation; 4. There are bacterial, viral, or fungal infections that require systemic treatment; 5. Participants deemed unsuitable by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor lesion identification index;Tumor lesion identification with radiotracer;Adverse reactions of radiotracer; | — |
Countries
China
Contacts
Public ContactFu Wei
The First Affiliated Hospital of Guilin Medical University
Outcome results
None listed